STOCK TITAN

WPCA-U - WPCA-U STOCK NEWS

Welcome to our dedicated page for WPCA-U news (Ticker: WPCA-U), a resource for investors and traders seeking the latest updates and insights on WPCA-U stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect WPCA-U's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of WPCA-U's position in the market.

Rhea-AI Summary

Warburg Pincus Capital Corporation I-A (NYSE: WPCA.U) announced that starting April 26, 2021, holders of its IPO units can separately trade Class A ordinary shares and warrants. The units will continue to trade as WPCA.U, while separated shares and warrants will trade under WPCA and WPCA WS, respectively. No fractional warrants will be issued. The IPO, completed on March 9, 2021, was co-managed by Citigroup, Credit Suisse, and Evercore. This release does not constitute an offer to sell or buy securities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Warburg Pincus Capital Corporation I-A announced the pricing of 25,000,000 units at $10.00 each, set to list on the NYSE under symbol WPCA.U starting March 5, 2021. Each unit comprises one Class A ordinary share and one-fifth of a warrant, entitling holders to buy a share at $11.50. The IPO closes on March 9, 2021, pending standard conditions. Joint bookrunners include Citigroup, Credit Suisse, and Evercore, with an option for underwriters to purchase an additional 3,750,000 units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
WPCA-U

NYSE:WPCA-U

WPCA-U Rankings

WPCA-U Stock Data